Mulyanusa Amarullah Ritonga
No ORCID on file
· 13 papers in corpus
· active 2023-2026
Study types
- other 5
- article 4
- case-report 1
- paratext 1
- preprint 1
Condition tags
- endometriosis 10
- endometrioma 6
- dysmenorrhea 3
- infertility 3
- chronic_pelvic_pain 2
- dyspareunia 1
- mesh:D004715 1
- adenomyosis 1
Top journals
Frequent coauthors
case-report
2026
BACKGROUND: The etiology of adenomyosis remains uncertain, and factors such as pregnancy, postpartum endometritis, cesarean delivery, uterine surgery, and uterine trauma are suspected to cause myometrial disruption that may trigger smooth m…
other
2026
PURPOSE: Endometriosis is one of the main reproductive issues that the modifiable risk factors is still the main research focus. It is still unclear how various adiposity affect the onset and spread of endometriosis because some studies hav…
other
2026
OBJECTIVE: Endometriosis is a chronic gynecological disease associated with inflammation and severe pelvic pain in 6%-10% of women of reproductive age. Although the pathophysiology and management of endometriosis are currently understood, f…
other
2026
INTRODUCTION: Endometriosis is a major gynecologic health issue affecting ~10% of women and girls of reproductive age worldwide. Despite its high prevalence, no curative treatment exists. Early diagnosis and treatment are critical to preven…
other
2026
Endometriomas are a frequent cause of infertility in reproductive-aged women, often requiring surgery. However, cystectomy for large endometriomas may reduce ovarian reserve, as indicated by decreased anti-Müllerian hormone (AMH) levels. Th…
article
2026
Background & Objective: The link between endometrioma and serum Anti-Müllerian Hormone (AMH) levels is crucial in predicting outcomes and informing clinical management strategies for affected individuals. Endometrioma may reduce ovarian res…
other
2025
Endometriosis is a chronic inflammatory disease characterized by the presence of endometrial-like tissues (glands and stroma) located outside the uterine cavity. The pathophysiology of this condition remains incompletely understood. Local b…
review
2025
Background: Elagolix, Linzagolix, and Relugolix, as oral gonadotropin-releasing hormone antagonists, have emerged as promising treatments for endometriosis-associated pain. Objective: To evaluate pain intensity reduction as the primary outc…
article
2025
Background: Endometriosis involves the presence of endometrial-like tissue outside the uterus, driven by inflammatory pathways including elevated interleukin-32 and vascular endothelial growth factor. One potential anti-inflammatory agent i…
preprint
2024
article
2023
Objective: To identify the characteristics of endometrioma recurrence cases. Method: This study was a descriptive retrospective, using secondary data taken from all medical records of Clinic Aster and Medical Records Installation in Dr. Has…
article
2023
Objective: To identify the characteristics of endometrioma recurrence cases. Method: This study was a descriptive retrospective, using secondary data taken from all medical records of Clinic Aster and Medical Records Installation in Dr. Has…
paratext
2023
Objective : To identify the characteristics of endometrioma recurrence cases. Method : This study was a descriptive retrospective, using secondary data taken from all medical records of Clinic Aster and Medical Records Installation in Dr. H…